Cargando…

Arguments for Using Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism

(1) Background: Patients with cancer with a hypercoagulable state present an increased incidence of venous thromboembolism (VTE). Neoplastic patients with concurrent VTE undergoing anticoagulant treatment face a series of issues. (2) The aim of the present paper is to systematically summarize curren...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiorescu, Roxana Mihaela, Mocan, Mihaela, Stoia, Mirela Anca, Barta, Anamaria, Goidescu, Cerasela Mihaela, Chiorescu, Stefan, Farcaş, Anca Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535422/ https://www.ncbi.nlm.nih.gov/pubmed/34682967 http://dx.doi.org/10.3390/healthcare9101287

Ejemplares similares

Biomarkers of Inflammation in Left Ventricular Diastolic Dysfunction
por: Mocan, Mihaela, et al.
Publicado: (2019)

ACE2 and Apelin-13: Biomarkers with a Prognostic Value in Congestive Heart Failure
por: Goidescu, Cerasela Mihaela, et al.
Publicado: (2021)

Short-Term Prognosis Value of sST2 for an Unfavorable Outcome in Hypertensive Patients
por: Farcaş, Anca Daniela, et al.
Publicado: (2020)

Severe Thrombocytopenia as a Manifestation of COVID-19 Infection
por: Mocan, Mihaela, et al.
Publicado: (2022)

Usefulness of the Adipokines as Biomarkers of Ischemic Cardiac Dysfunction
por: Mocan Hognogi, Larisa-Diana, et al.
Publicado: (2018)

Better prognosis in overweight/obese coronary heart disease patients with high plasma levels of leptin
por: SIMITI, LUMINITA ANIMARIE VIDA, et al.
Publicado: (2016)

Serum Soluble ST2 and Diastolic Dysfunction in Hypertensive Patients
por: Farcaş, Anca Daniela, et al.
Publicado: (2017)

Biomarkers of Volume Overload and Edema in Heart Failure With Reduced Ejection Fraction
por: Chiorescu, Roxana Mihaela, et al.
Publicado: (2022)

Oral Anticoagulant Therapy—When Art Meets Science
por: Cîmpan, Patricia Lorena, et al.
Publicado: (2019)

Vulnerable Atherosclerotic Plaque: Is There a Molecular Signature?
por: Chiorescu, Roxana Mihaela, et al.
Publicado: (2022)

Dilated cardiomyopathy produced by lamin A/C gene mutations
por: GOIDESCU, CERASELA MIHAELA
Publicado: (2013)

Direct oral anticoagulants and venous thromboembolism
por: Franchini, Massimo, et al.
Publicado: (2016)

Cardiac Rehabilitation Early after Sternotomy Using New Assistive VR-Enhanced Robotic Exoskeleton—Study Protocol for a Randomised Controlled Trial
por: Mocan, Mihaela, et al.
Publicado: (2021)

Hemodynamic monitoring using thoracic bioimpedance – an optimal solution for the treatment of hypertension
por: FARCAS, ANCA DANIELA, et al.
Publicado: (2018)

The Apelin-APJ System in the Evolution of Heart Failure
por: GOIDESCU, CERASELA MIHAELA, et al.
Publicado: (2015)

Direct Oral Anticoagulants and Travel-related Venous Thromboembolism
por: Chamnanchanunt, Supat, et al.
Publicado: (2018)

Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Japan
por: Nakamura, Mashio, et al.
Publicado: (2017)

Direct oral anticoagulants for unusual‐site venous thromboembolism
por: Riva, Nicoletta, et al.
Publicado: (2021)

Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism
por: Masini, Marta, et al.
Publicado: (2023)

Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2021)

Direct Oral Anticoagulants or Standard Anticoagulant Therapy in Fragile Patients with Venous Thromboembolism
por: López-Núñez, Juan J., et al.
Publicado: (2019)

Electrocardiographic Patterns in Patients with Neurally Mediated Syncope
por: Țentea, Călina-Patricia, et al.
Publicado: (2021)

Direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism
por: Yhim, Ho-Young, et al.
Publicado: (2014)

Direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer
por: Planquette, Benjamin, et al.
Publicado: (2019)

Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients
por: Song, Andrew B, et al.
Publicado: (2019)

Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulants
por: Ay, C, et al.
Publicado: (2019)

Recent advances in the treatment of venous thromboembolism in the era of the direct oral anticoagulants
por: Weitz, Jeffrey I., et al.
Publicado: (2017)

The Use of Direct Oral Anticoagulants in the Management of Venous Thromboembolism in Patients With Obesity
por: Younis, Moustafa, et al.
Publicado: (2020)

The role of direct oral anticoagulants in venous thromboembolic disease in gynecologic cancer
por: Park, Jeong-Yeol
Publicado: (2019)

Role of Direct Oral Anticoagulants for Post-operative Venous Thromboembolism Prophylaxis
por: Tun, Han Naung, et al.
Publicado: (2022)

Surgical technique of concomitant laparoscopically assisted vaginal hysterectomy and laparoscopic cholecystectomy
por: STANCU, BOGDAN, et al.
Publicado: (2017)

Chronic hepatitis C virus infection: a new modifiable cardio-metabolic risk factor?
por: CUCIUREANU, TUDOR, et al.
Publicado: (2017)

Mixed Etiology COVID-19 Associated Pulmonary Aspergillosis (CAPA)—A Case Report and Brief Review of the Literature
por: Toc, Dan Alexandru, et al.
Publicado: (2021)

Efficacy of Direct Oral Anticoagulant into the Care of Venous Thromboembolism Related to Kumamoto Earthquake
por: Matsukawa, Mai, et al.
Publicado: (2018)

Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism
por: Zeng, Jie, et al.
Publicado: (2019)

Current Management of Cancer-associated Venous Thromboembolism: Focus on Direct Oral Anticoagulants
por: Kim, Sang-A, et al.
Publicado: (2019)

Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study
por: Campello, Elena, et al.
Publicado: (2020)

Derivation of the non-inferiority margin for the evaluation of direct oral anticoagulants in the treatment of venous thromboembolism
por: Prins, Martin H, et al.
Publicado: (2013)

Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017
por: Lutsey, Pamela L., et al.
Publicado: (2019)

Direct oral anticoagulants for the treatment and prevention of venous thromboembolism in patients with cancer: current evidence
por: García-Escobar, I., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nl33gu3hsfv2ar1jimsqnd809v